Page last updated: 2024-08-24

rhodamine 123 and doxorubicin(6-maleimidocaproyl)hydrazone

rhodamine 123 has been researched along with doxorubicin(6-maleimidocaproyl)hydrazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abu Ajaj, K; Graeser, R; Kratz, F	1

Other Studies

1 other study(ies) available for rhodamine 123 and doxorubicin(6-maleimidocaproyl)hydrazone

Article	Year
Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin. Breast cancer research and treatment, 2012, Volume: 134, Issue:1 Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Dibenzocycloheptenes; Doxorubicin; Drug Carriers; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Drug Synergism; Female; Fluorescent Dyes; Humans; Hydrazones; Hydrolysis; Inhibitory Concentration 50; Prodrugs; Quinolines; Rhodamine 123; Serum Albumin	2012

Article

Year

Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.

Breast cancer research and treatment, 2012, Volume: 134, Issue:1

Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Dibenzocycloheptenes; Doxorubicin; Drug Carriers; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Drug Synergism; Female; Fluorescent Dyes; Humans; Hydrazones; Hydrolysis; Inhibitory Concentration 50; Prodrugs; Quinolines; Rhodamine 123; Serum Albumin

2012